Skip to main content
Premium Trial:

Request an Annual Quote

Gregory Liberman, Steven Kriegsman, and Robert Brown

Premium

CytRx announced this week that it has appointed Gregory Liberman as the company’s general counsel and corporate secretary.

In these roles, CytRx said that Liberman is responsible for managing the company’s worldwide legal affairs, policy, and strategy. He will report to CytRx CEO Steven Kriegsman and will serve as secretary to the company’s board of directors.

Liberman has previously worked as a strategic consultant to both private and public companies, said CytRx. He has also served as vice president of legal and corporate affairs, as well as associate general counsel, at Exodus Communications. Prior to this, he was vice president of corporate development and associate general counsel at GlobalCenter.

Lieberman holds a JD from the University of Chicago Law School.

CytRx also announced this week that Robert Brown, founder and director of the Cecil B. Day Laboratory of Neuromuscular Research at Massachusetts General Hospital, has joined the company’s scientific advisory board.

Brown is a professor of neurology at Harvard Medical School and is a recognized expert in the field of neuromuscular diseases such as amyotrophic lateral sclerosis, said CytRx.

Brown is also a member of the Institute of Medicine, the Academy of Neurology, and the American Neurological Association, said the company. He graduated from Harvard Medical School and completed his doctoral training at Oxford University.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.